ROIV
Roivant Sciences Ltd. · Healthcare
Pres, Immunovant CEO Eric Venker sold $6.1M of Roivant Sciences Ltd.
Sold$6,054,000
$30.27Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Tue, May 26 open, $29.98
- +22.8%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Jul 9 close.
Traded Fri, May 22. Filed Fri, May 22, 6:25 PM ET, after the close. Returns use the May 26 open and the Jul 9 close. Not investment advice.